Multi-fidelity surrogates (MFS) have become a popular way to combine small number of expensive high-fidelity (HF) samples and many cheap low-fidelity (LF) samples. In some situations LF samples can come from multiple sources and sometimes the HF samples alone can obtain a more accurate surrogate than the combination (HF&LF). Therefore this paper considers using maximum likelihood (ML) and cross validation (CV) to select the dataset leading to best surrogate accuracy, when multiple sample sources are available. The kriging and co-kriging techniques were employed to build surrogates. Unlike conventional model selection, the multi-fidelity datasets selection by ML and CV has to compare the surrogate accuracy of different true functions. The effectiveness of ML and CV is examined through a two-variable turbine problem, where samples can come from one HF and two LF models. The indicators were used to select between using only HF samples or combining them with one set of LF samples or the other. The best selection proved to depend on the design of experiments (DOE), and so datasets were generated for a large number of DOEs. It was found the CV and ML worked relatively well in selection between two LF sample sources for MFS. When selecting between only HF and HF&LF, the ML, which is frequently used in co-kriging hyper-parameter estimation, failed in detecting when the surrogate accuracy of only HF was better than HF & LF. The CV was successful only part of the time. The reasons behind the poor performance are analyzed with the help of a 1D example.
Structural and Multidisciplinary Optimization – Springer Journals
Published: May 25, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud